Brand
Harbin Jixianglong Biotech Co., Ltd.
2 federal recalls on file. We monitor every CPSC, FDA, USDA, and NHTSA notice for Harbin Jixianglong Biotech Co., Ltd. and translate it into plain English — free weekly digest, optional same-day alerts.
- 2026-03-11FDA-DrugClass IISemaglutide, For Rx compounding use only, packaged in a) 1g, NDC 84385-106-01; b) 5g, NDC 84385-106-02; c) 10g, NDC 84385-106-06; d) 25g, NDC 84385-106-03; d) 50g, NDC 84385-106-04; e) 100g, NDC 84385-106-05Manufacturer: Harbin Jixianglong Biotech Co., Ltd., North of Baoan Road, East of Changqing Street, Limin Development Zone, Harbin, China.
CGMP Deviations This recall has been initiated due to failing to complete process validation and bacterial endotoxin method validation before distribution
- 2026-03-11FDA-DrugClass IISemaglutide, For Rx compounding use only, packaged in a) 1g, NDC 84385-106-01; b) 5g, NDC 84385-106-02; c) 10g, NDC 84385-106-06; d) 25g, NDC 84385-106-03; d) 50g, NDC 84385-106-04 Manufacturer: Harbin Jixianglong Biotech Co., Ltd., North of Baoan Road, East of Changqing Street, Limin Development Zone, Harbin, China
CGMP Deviations This recall has been initiated due to failing to complete process validation and bacterial endotoxin method validation before distribution
Get notified about new Harbin Jixianglong Biotech Co., Ltd. recalls
Free weekly digest. We email when a new federal recall affects Harbin Jixianglong Biotech Co., Ltd. or anything else in your household.
Get the Sunday Brief